Exact Sciences Corp
(NAS:EXAS)
$
54.21
-0.51 (-0.93%)
Market Cap: 10.03 Bil
Enterprise Value: 11.77 Bil
PE Ratio: 0
PB Ratio: 3.12
GF Score: 80/100 Exact Sciences Corp at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021 / 04:50PM GMT
Release Date Price:
$136.39
(-2.72%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
All right. Good morning, everybody. My name is Doug Schenkel from the Cowen Life Science and Diagnostic Tools team. It's my pleasure to welcome you to the 41st Annual Cowen and Company Health Care Conference, and also to welcome you to this session specifically with Exact Sciences' Chairman and Chief Executive Officer, Kevin Conroy; and the company's Chief Financial Officer, Jeff Elliott. Thanks to the 2 of you for being with us today.
Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO
Hi, Doug. Thanks for having us.
Questions & Answers
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
So I wanted to start on the topic of strategic positioning and strategic evaluation. And I don't think any of us technically thought of Exact being a 1-product company for the last few years, but I think it was kind of viewed that way by many, for good or
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot